InvestorsHub Logo
Followers 96
Posts 4823
Boards Moderated 0
Alias Born 02/07/2021

Re: LessIsMore post# 601360

Wednesday, 06/14/2023 10:22:16 AM

Wednesday, June 14, 2023 10:22:16 AM

Post# of 705331
The trial showed an increase in overall survival. It didn't contain subgroup analysis which only occurs when the primary endpoints fail. We met all endpoints with super statistical significance as well as hazard ratios that show the results were not random.

The idea that DCVax doesn't benefit all patients vs SOC isn't true otherwise it wouldn't be the focal point of UCLA research for GBM. Some respond better than others but by in large it works well enough for approval.

Do your own research. I am not providing legal or investment advice. This is an anonymous forum for entertainment purposes only. Don't trust anything you read.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News